Cullinan Oncology to Present New Preclinical Data for
CLN-619 is a MICA/B directed humanized IgG1 antibody being studied in a global Phase 1 clinical trial in patients with
Globe Newswire15-03-2023, 03:39
Fortinet Survey Finds 78% of Organizations Felt Prepared for Ransomware Attacks, Yet Half Still Fell Victim 24-04-2023, 20:00
